The ALLHAT-LLT and ASCOT-LLA trials: Are the discrepancies more apparent than real? Charles H. Hennekens OriginalPaper Pages: 9 - 11
Noninvasive atherosclerosis imaging for predicting cardiovascular events and assessing therapeutic interventions Douglas S. JacobyEmile R. Mohler IIIDaniel J. Rader OriginalPaper Pages: 20 - 26
Multitasking of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor: Beyond cardiovascular diseases Paolo CalabroEdward T. H. Yeh OriginalPaper Pages: 36 - 41
Role of selective cholesterol absorption inhibition in the management of dyslipidemia Christie M. Ballantyne OriginalPaper Pages: 52 - 59
Emerging, noninvasive surrogate markers of atherosclerosis Samir N. PatelVenkataraman RajaramSteven B. Feinstein OriginalPaper Pages: 60 - 68